Warning letter
Aviralex Int.: warning letter of Mar 3, 2008
FDA warning letter UCM1048383 · San Francisco District Office
Key facts
| Reference number | UCM1048383 |
|---|---|
| Company | Aviralex Int. |
| Subject | Drug Labeling/Promotional Claims/Misbranded |
| Issue date | Mar 3, 2008 |
| Posted date | Mar 3, 2008 |
| Issuing office | San Francisco District Office |
| Product type | Drugs |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: